Skip to content

Comparison of therapeutic effects of different dialysis methods in ESRD with HFpEF

Comparison of therapeutic effects of different dialysis methods in ESRD with HFpEF

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060301
Enrollment
Unknown
Registered
2022-05-26
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ESRD with HFpEF

Interventions

Group 1 :
Group 2:

Sponsors

Jilin University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed with stage 5 chronic kidney disease; 2. Based on the 2016 European heart failure guidelines combined with the 2021 European heart failure guidelines on the diagnostic criteria for HFpEF; 3. New York heart function (NYHA) class I-IV; 4. Patients who undergo hemodialysis or peritoneal dialysis in our hospital for the first time; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors, blood system diseases, uncontrolled neuroendocrine system and mental system disorders; 2. Serum albumin < 20 g/L, hemoglobin < 30 g/L and other severe malnutrition; 3. Recently (within 90 days) combined with acute myocardial infarction, cerebral infarction, cerebral hemorrhage and other serious cardiovascular and cerebrovascular events; 4. Patients with congenital heart disease, hypertrophic obstructive cardiomyopathy, acute myocarditis, restrictive cardiomyopathy, large vessel aneurysm, aortic dissection, undiagnosed rheumatic and senile degenerative heart valve disease.

Design outcomes

Primary

MeasureTime frame
Renal function index;Cardiac function index;NYHA classification;Biochemical detection;Number of rehospitalizations for heart failure;

Countries

China

Contacts

Public ContactCui Wenpeng

Jilin University Second Hospital

wenpengcui@163.com+86 13504316157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026